| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Network Foundations is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Interactive Health Solutions, Inc. (IHS) was founded in 1992 and is based in Arlington Heights, IL. Today, IHS is the nation's premier Population Health Management Company.
Ernest Gallo Clinic and Research Center is a Emeryville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Gladden Longevity is a comprehensive concierge medical program dedicated to health optimization and performance, with a focus on age reversal. They offer wellness and fitness services, neurocognitive testing, body composition analysis, cardiovascular p...